Trends in prevalence of prognostic factors and survival in lung cancer patients from 1985 to 2004 at a tertiary care center

Cancer Detection and Prevention

Volumn 32, Issue 2, 2008, Pages 101-108

  Kachroo, Sumesh ^a   Tong, L ^a   Spitz, Margaret R ^a   Xing, Yun ^a   Merriman, Kelly ^a   Zhu, Dakai K ^a   Fueger, John ^a   Amos, Christopher I ^a   Etzel, Carol J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Age at diagnosis; Body mass index; Ethnicity; Family history; Gender; Histology; Lung cancer survival; Predictors for lung cancer survival; Self administered questionnaire; Smoking history; Time trends; Tumor stage

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CIGARETTE SMOKING; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HUMAN; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; STRUCTURED QUESTIONNAIRE; TERTIARY HEALTH CARE; TREND STUDY;

FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; QUESTIONNAIRES; RISK FACTORS; SMOKING;

EID: 47749117131     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2008.05.009     Document Type: Article

References (27)

1. American Cancer Society. Cancer facts and figures 2008. Atlanta GA: American Cancer Society; 2008. Available from: http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf [cited February 21, 2008].
2. Zang E.A., and Wynder E.L. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst 88 February 21 (3/4) (1996) 183-192
3. American cancer Society. Cancer deaths drop for second consecutive year. Atlanta GA: American Cancer Society; 2007. Available from: http://www.cancer.org/docroot/MED/content/MED_2_1x_Cancer_Deaths_Drop_for_Second_Consecutive_Year.asp?sitearea=MED [cited June 26, 2007].
4. Fu J.B., Kau T.Y., Severson R.K., and Kalemkerian G.P. Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database. Chest 127 3 (2005) 768-777
5. Surveillance, Epidemiology, and End Results (SEER) 1993-2003 public-use data. Bethesda MD: National Cancer Institute; 2007. Available from: http://seer.cancer.gov/ [cited September 6, 2007].
6. Ferguson M.K., Skosey C., Hoffman P.C., and Golomb H.M. Sex-associated differences in presentation and survival in patients with lung cancer. J Clin Oncol 8 (1990) 1402-1407
7. McDuffie H.H., Klaassen D.J., and Dosman J.A. Female-male differences in patients with primary lung cancer. Cancer 59 (1987) 1825-1830
8. Johnson B.E., Steinberg S.M., Phelps R., Edison M., Veach S.R., and Ihde D.C. Female patients with small cell lung cancer live longer than male patients. Am J Med 85 (1988) 194-196
9. Wolf M., Holle R., Hans K., Drings P., and Havemann K. Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): the role of sex as a predictor for survival. Br J Cancer 63 (1991) 986-992
10. Radzikowska E., Glaz P., and Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases. Ann Oncol 13 (2002) 1087-1093
11. Visbal A.L., Williams B.A., Nichols III F.C., Marks R.S., Jett J.R., Aubry M.C., et al. Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002. Ann Thorac Surg 78 1 (2004) 209-215
12. Travis W.D., Lubin J., Ries L., and Devesa S. United States lung carcinoma incidence trends: declining for most histologic types among males, increasing among females. Cancer 77 12 (1996) 2464-2470
13. Zheng T., Holford T.R., Boyle P., Chen Y., Ward B.A., Flannery J., et al. Time trend and the age-period-cohort effect on the incidence of histologic types of lung cancer in Connecticut, 1960-1989. Cancer 74 5 (1994) 1556-1567
14. Morgan L.C., Grayson D., Peters H.E., Clarke C.W., and Peters M.J. Lung cancer in New South Wales: current trends and the influence of age and sex. Med J Aust 172 12 (2000) 578-582
15. Yoshimi I., Ohshima A., Ajiki W., Tsukuma H., and Sobue T. A comparison of trends in the incidence rate of lung cancer by histological type in the Osaka Cancer Registry, Japan and in the Surveillance, Epidemiology and End Results Program, USA. Jpn J Clin Oncol 33 2 (2003) 98-104
16. Pignon J.P., Arriagada R., Ihde D.C., Johnson D.H., Perry M.C., Souhami R.L., et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 327 23 (1992) 1618-1624
17. Warde P., and Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 10 6 (1992) 890-895
18. Cote M.L., Kardia S.L., Wenzlaff A.S., Ruckdeschel J.C., and Schwartz A.G. Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer. JAMA 293 24 (2005) 3036-3042
19. Kitajima T., Nishii K., Ueoka H., Shibayama T., Gemba K., Kodani T., et al. Recent improvement in lung cancer screening: a comparison of the results carried out in two different time periods. Acta Med Okayama 60 3 (2006) 173-179
20. Ugnat A.M., Xie L., Semenciw R., Waters C., and Mao Y. Survival patterns for the top four cancers in Canada: the effects of age, region and period. Eur J Cancer Prev 14 2 (2005) 91-100
21. Helgesen F., Holmberg L., Johansson J.E., Bergstrom R., and Adami H.O. Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst 88 17 (1996) 1216-1221
22. Post P.N., Kil P.J., and Coebergh J.W. Trends in survival of prostate cancer in southeastern Netherlands, 1971-1989. Int J Cancer 81 4 (1999) 551-554
23. Du W.B., Chia K.S., Sankaranarayanan R., Sankila R., Seow A., and Lee H.P. Population-based survival analysis of colorectal cancer patients in Singapore, 1968-1992. Int J Cancer 99 3 (2002) 460-465
24. Marchevsky A.M. Problems in pathologic staging of lung cancer. Arch Pathol Lab Med 130 3 (2006) 292-302
25. Pelletier M.P., Edwardes M.D., Michel R.P., Halwani F., and Morin J.E. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis. Can J Surg 44 3 (2001) 180-188
26. Birim O., Kappetein A.P., van Klaveren R.J., and Bogers A.J. Prognostic factors in non-small cell lung cancer surgery. Eur J Surg Oncol 32 February (1) (2006) 12-23
27. Noel G., Medioni J., Valery C.A., Boisserie G., Simon J.M., Cornu P., et al. Three irradiation treatment options including radiosurgery for brain metastases from primary lung cancer. Lung Cancer 41 (2003) 333-343